Back to Results
First PageMeta Content
CTLA-4 / Protein kinase inhibitor / Bristol-Myers Squibb / Ipilimumab / Melanoma


Toxicity from Checkpoint Inhibitors James Larkin FRCP PhD Disclosures
Add to Reading List

Document Date: 2015-05-04 13:05:47

Open Document

File Size: 541,16 KB

Share Result on Facebook
UPDATE